Full Text View
Tabular View
No Study Results Posted
Related Studies
Dextro-Amphetamine Versus Caffeine in Treatment-Resistant OCD
This study has been completed.
Study NCT00363298   Information provided by Stanford University
First Received: August 9, 2006   Last Updated: April 3, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obsessive-Compulsive Disorder
More general conditions related to this trial
Anxiety Disorders
Mental Disorders
Interventions listed in this trial
dextro-amphetamine
Additional drug interventions recognized in this trial
Amphetamine
Dextroamphetamine
Methamphetamine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Autonomic Agents
Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sympathomimetics
Therapeutic Uses
Sponsors listed in this trial
Stanford University
Obsessive Compulsive Foundation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services